mRNA is abundant in the liver and testis, and present at lower levels in other tissues.
INTRODUCTION
Vitamin D regulates calcium and phosphate metabolism by activating the vitamin D receptor, a transcription factor and member of the nuclear receptor family. In the 1920s, McCollum, Mellanby, and Pappenheimer showed that deficiency of vitamin D caused rickets in experimental animals (1) . Subsequently, the structure of vitamin D and its origins from plant and animal steroids were determined, and the roles of the vitamin in the mobilization of minerals from the diet and in bone were defined. The liver was shown to be required for the activation of vitamin D by 25-hydroxylation (2, 3) . While 25-hydroxyvitamin D was more active than vitamin D in many bioassays (4) , the most potent hormone was 1α,25-dihydroxyvitamin D (5,6), which was synthesized from 25-hydroxyvitamin D by the kidney (7) . The molecular mechanism of vitamin D action were manifest with the identification (8) and cDNA cloning (9) Expression Cloning -A cDNA library was made from 3 µg of poly(A) + hepatic RNA isolated from mice deficient in sterol 27-hydroxylase (25) using the SUPERSCRIPT plasmid system for cDNA synthesis (Invitrogen Life Technologies). cDNA synthesis was initiated by NotI oligo(dT) primer-adapters, the cDNA products were ligated to SalI adapters, digested with the restriction enzyme NotI, size-fractionated by gel filtration chromatography, and then ligated into NotI and SalI digested pCMV-SPORT 6 vector.
Nucleic acids in the ligation mixture were precipitated with ethanol and resuspended in 5- Vitamin D Receptor Activation Assay and Ligands -The GAL4-VDR/GAL4-Luciferase receptor-reporter system was composed of the pTK-MH100X4-LUC plasmid (27) , and pCMX/GAL4-VDR, which specifies a fusion protein consisting of amino acids 1-147 of To determine the maximum number of cDNAs that could be assayed at one time in the expression screen, dilution experiments were performed with the sterol 27-hydroxylase (CYP27A1) expression plasmid, the receptor-reporter system, and the precursor substrate, 1α-hydroxyvitamin D 3 . A luciferase enzyme activity that was threefold over background was observed when the sterol 27-hydroxylase plasmid was diluted confirmed that the sterol 27-hydroxylase enzyme is capable of 25-hydroxylating both vitamin D 3 and 1α-hydroxyvitamin D 3 (11, 34, 35) .
To avoid isolating cDNAs encoding the sterol 27-hydroxylase, the cDNA library used in these studies was constructed using poly(A) + mRNA isolated from livers of mice lacking sterol 27-hydroxylase (25). The resulting library was estimated to contain 7.9 x 10 6 independent transformants with an average cDNA insert size of 1.5 kilobases (kb).
Aliquots of the library containing ~100 cDNAs were transfected together with the GAL4-VDR/GAL4-Luciferase receptor-reporter plasmids into HEK 293 cells. The data generated from one such experiment is shown in Fig /EBI Data Bank accession number AY323817) was generated from a cDNA isolated from liver mRNA using PCR (Fig. 2A) . The two enzymes share 89% sequence identity at the amino acid level ( Fig. 2A) , and the coding regions of the two cDNAs share 89% identity at the nucleic acid level. The human CYP2R1 gene is located luciferase expression approximately 7-10-fold in the GAL4-VDR/GAL4-luciferase reporter system (Fig. 3A) . A similar stimulation was observed when a plasmid encoding the mouse sterol 27-hydroxylase (mCYP27A1) was introduced into the HEK 293 cells.
As negative controls, neither the expression vector alone (pCMV6), nor a vector expressing the human cytochrome P450 3A4 cDNA (hCYP3A4), stimulated the expression of luciferase enzyme activity (Fig. 3A) .
Similar responses were ascertained when the receptor-reporter system was switched to one composed of the intact vitamin D receptor and a luciferase reporter gene driven by three copies of a vitamin D response element from the mouse osteopontin gene linked to a basal TK promoter (Fig. 3B) . Plasmids expressing these genes are referred to as the VDR/VDRE-Luciferase system. Here, expression of the human or mouse CYP2R1 cDNAs led to marked stimulation of luciferase enzyme activity (16-and 17- fold, respectively), as did expression of the mCYP27A1 cDNA (18-fold).
The final receptor-reporter system tested was composed of the intact vitamin D receptor and a 0.862 kb DNA fragment encompassing the promoter of the mouse osteopontin gene linked to the luciferase reporter gene (VDR/Osteopontin-Luciferase).
Previous studies showed that the osteopontin regulatory sequences contain a bona-fide vitamin D responsive element (36). The basal luciferase expression level observed in this system in the presence of the control CMV or hCYP3A4 plasmids was substantial ( also has significant agonist activity (Fig. 3) ; and third, there is a low level of endogenous CYP2R1 enzyme activity expressed in the HEK 293 cells, which is very active against 1α-hydroxyvitamin D 3 generated in situ following transfection with the CYP27B1 cDNA.
Despite these challenges, informative data were generated in transfection experiments with the various P450 expression vectors. As shown in Fig. 4A , when the GAL4-VDR/GAL4-Luciferase system was employed using vitamin D 3 To determine the specificity of CYP2R1, the capacity of the encoded protein to activate or inactivate ligands for other nuclear receptors was determined. Expression of human CYP2R1 cDNA was found to have no effect on the abilities of the following (Fig. 5A) . Saturation of the response system was reached when 10 ng of P450 expression plasmid was added to the cells. A similar hyperbolic curve was observed when the mouse CYP27A1 expression plasmid was used but the relative level of enzyme activity measured at saturation was 50% less, which may be a consequence of an intrinsically lower activity of the CYP27A1 enzyme against 1α-hydroxyvitamin D 3 (11) . No increase in luciferase enzyme activity was observed when mouse adrenodoxin or human CYP3A4 were expressed in these cells (Fig. 5A ).
In the second experiment, levels of vitamin D 3 were varied and the amounts of the P450 expression plasmids were held constant (Fig. 5B) . In these experiments, CYP2R1
was more robust than CYP27A1 in generating an active receptor at low levels of vitamin The tissue distribution of the CYP2R1 mRNA was determined in the mouse by real time PCR and compared to those of the CYP27A1 sterol 27-hydroxylase, CYP27B1
vitamin D 1α-hydroxylase, and CYP24A1 vitamin D 24-hydroxylase mRNAs (Fig. 9) .
These experiments revealed that CYP2R1 mRNA was most abundant in the liver and testis 2 and present in lower levels in numerous other tissues and cell types. The CYP27A1 mRNA was present at high levels in liver and muscle, and detectable in all other tissues tested. As expected, the CYP27B1 and CYP24A1 mRNAs were most abundant in the kidney and present in much lower amounts in other tissues. Inasmuch as threshold values (C T ) determined for different mRNAs with different primer pairs can be compared, it is interesting to note that the C T s for the CYP2R1, CYP27B1, and CYP24A1 mRNAs in the liver and kidney are in the same range (C T = 25-26), whereas that for the hepatic CYP27A1 mRNA is far higher (C T = ~18). In separate experiments for which the data are not shown, the C T values determined for the CYP2R1 mRNA in male and female mouse liver were 24.7 and 24.6, respectively, indicating the absence of sexual dimorphism in the expression of this gene. which is located towards the carboxyl-terminus and includes the cysteine ligand of the heme co-factor (40) . The mouse CYP2R1 is 89% identical in sequence to the human enzyme ( Fig. 2A) , and is conserved through evolution at least through the bony fish Although the typical order of vitamin D hydroxylation events is thought to be 25-hydroxylation in the liver followed by 1α-hydroxylation in the kidney or other target tissues (22) , biochemical data show that the microsomal 25-hydroxylase also is capable of utilizing the 1α-form of the vitamin as a substrate (34) .
In several experiments (e.g., Fig. 5B, 8B ), the mitochondrial CYP27A1 enzyme was more active at higher concentrations of vitamin D 3 substrate than was CYP2R1.
This behavior represents a third line of evidence in support of CYP2R1 being the microsomal vitamin D 25-hydroxylase since in vivo data (42) and in vitro data (10, 43, 44) suggest that the mitochondrial hydroxylase is a low-affinity, high capacity enzyme whereas the microsomal hydroxylase is a high-affinity, low capacity enzyme. While the reasons for these apparently different kinetic properties were not determined here, future experiments with the recombinant CYP27A1 and CYP2R1 enzymes should reveal whether they are related to transport of the vitamin into the mitochondrion or microsome, differences in the biochemical characteristics of the two enzymes, or other parameters.
The tissue distribution of the encoding mRNA represents a fourth line of evidence that CYP2R1 is the microsomal 25-hydroxylase (Fig. 7) . In the rat, and presumably the In addition, the human CYP2R1 sequence shares little identity with a P450 enzyme isolated from the bacterium Amycolata autotrophica that has vitamin D 25-hydroxylase activity (51) . Whether the limited sequence identity between these enzymes can be used Assuming a one-to-one correspondence between these activities and the production of 25-hydroxyvitamin D in vivo suggests that the microsomal enzyme is responsible for ~30% of total activity and the mitochondrial enzyme 70%. A comparison of CYP2R1 and CYP27A1 mRNA levels provides further insight into this question. As determined in real time PCR experiments, the C T value for CYP2R1 mRNA in liver was ~24.9, while that for the CYP27A1 mRNA was ~17.8 ( Fig. 7) . This result indicates that CYP27A1 is the more abundant enzyme in the liver.
Extrapolation of these data, which suggest that CYP27A1 synthesizes a majority 
